Angion Biomedica Corp Financials

Angion Biomedica Stock Summary

Angion Biomedica competes with Apollomics, Pyxis Oncology, Zura Bio, Elevation Oncology, and ZyVersa Therapeutics. Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company was incorporated in 1998 and is based in Uniondale, New York. Angion Biomedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 37 people.

Angion Biomedica Key Financial Ratios

Angion Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Angion Biomedica's current stock value. Our valuation model uses many indicators to compare Angion Biomedica value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Angion Biomedica competition to find correlations between indicators driving Angion Biomedica's intrinsic value. More Info.Angion Biomedica Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Angion Biomedica's earnings, one of the primary drivers of an investment's value.

Angion Biomedica Market Pulse

Along with financial statement analysis, the daily predictive indicators of Angion Biomedica help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Angion Biomedica Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Angion Biomedica Corp based on widely used predictive technical indicators. In general, we focus on analyzing Angion Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Angion Biomedica's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.